2003
Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988–2000: Description and Determinants
Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano D. Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988–2000: Description and Determinants. American Journal Of Epidemiology 2003, 158: 695-704. PMID: 14507606, DOI: 10.1093/aje/kwg209.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug injection behaviorDrug usersIntravenous Experience (ALIVE) studyDrug treatment programsHistory of incarcerationLogistic regression modelsALIVE studySemiannual visitsMultinomial logistic regression modelsBaseline factorsChronic diseasesDrug injectionRecent overdoseCessation attemptsDrug use transitionsDrug injectorsCommunity outreach effortsLongitudinal patternsHigh mortalityEarly determinantsYounger ageTreatment programInjection behaviorStudy periodFeasibility of referring drug users from a needle exchange program into an addiction treatment program: Experience with a mobile treatment van and LAAM maintenance
Kuo I, Brady J, Butler C, Schwartz R, Brooner R, Vlahov D, Strathdee S. Feasibility of referring drug users from a needle exchange program into an addiction treatment program: Experience with a mobile treatment van and LAAM maintenance. Journal Of Substance Use And Addiction Treatment 2003, 24: 67-74. PMID: 12646332, DOI: 10.1016/s0740-5472(02)00343-4.Peer-Reviewed Original ResearchMeSH KeywordsAdultBaltimoreCocaine-Related DisordersFeasibility StudiesFemaleHeroin DependenceHumansMaleMethadyl AcetateMobile Health UnitsNarcoticsNeedle-Exchange ProgramsReferral and ConsultationSeverity of Illness IndexSubstance Abuse Treatment CentersSubstance-Related DisordersTime FactorsTreatment OutcomeConceptsTreatment programLevomethadyl acetate hydrochlorideFirst-line treatmentEarly treatment responseNeedle exchange programsCocaine-positive urine testsDrug treatment programsAddiction treatment programsLAAM maintenanceAgonist therapyLine treatmentOpioid dependenceUrine testsTreatment responseDrug usersNEP attendersHeroin addictionProgram attendersAlcohol useSubscale scoresProgram entrySignificant reductionAttendersLAAM
2000
Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals
Kuo I, Fischer B, Vlahov D. Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal Of Drug Policy 2000, 11: 357-370. PMID: 10967518, DOI: 10.1016/s0955-3959(00)00057-8.Peer-Reviewed Original ResearchMethadone treatmentMajor public health problemOpiate addictsAdditional treatment strategiesHeroin-assisted treatmentPrincipal treatment modalityPublic health problemOpiate-dependent individualsSubstance abuse treatmentTreatment modalitiesClinical trialsTreatment outcomesTreatment strategiesSide effectsEconomic burdenHealth problemsInjectable opiatesTreatment programAbuse treatmentTreatment participationEffective interventionsTreatmentPositive resultsAddictsRecent studiesCorrelates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus
Shah N, Celentano D, Vlahov D, Stambolis V, Johnson L, Nelson K, Strathdee S. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000, 14: 2035-2043. PMID: 10997409, DOI: 10.1097/00002030-200009080-00020.Peer-Reviewed Original ResearchMeSH KeywordsAdultBaltimoreCohort StudiesFemaleHealth Services AccessibilityHIV AntibodiesHIV InfectionsHIV SeronegativityHIV SeropositivityHumansMaleMethadoneMiddle AgedNeedle-Exchange ProgramsProspective StudiesRisk-TakingSocioeconomic FactorsSubstance Abuse Treatment CentersSubstance Abuse, IntravenousConceptsMethadone maintenance treatment programInjection drug usersMaintenance treatment programNeedle exchange programsHIV serostatusHIV-seronegative injection drug usersSeronegative injection drug usersHIV-negative injection drug usersTreatment programHIV-seropositive participantsHealth care providersTreatment slotsNeedle exchange program participantsAfrican AmericansHIV testProspective cohortCare providersDrug usersProgram attendanceOlder ageCertain subgroupsVulnerable populationsSimilar proportionsBehavioral factorsEnrollmentPrevention of HIV Infection in Street-Recruited Injection Drug Users
Monterroso E, Hamburger M, Vlahov D, Jarlais D, Ouellet L, Altice F, Byers R, Kerndt P, Watters J, Bowser B, Fernando M, Holmberg S. Prevention of HIV Infection in Street-Recruited Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 25: 63-70. PMID: 11064506, DOI: 10.1097/00042560-200009010-00009.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug usersHIV infectionInitial serum specimensLarge multicity studyHIV prevention strategiesHIV infection riskHIV prevention programsSyringe exchange programsDrug treatment programsUse of needlesNew AIDSHIV acquisitionHIV serostatusHIV casesPrevention strategiesSerum specimensSex partnersInfection ratePrevention programsTreatment programInfection riskStandard questionnaireHIVMultivariate modelPrevention of HIV Infection in Street-Recruited Injection Drug Users
Monterroso E, Hamburger M, Vlahov D, Jarlais D, Ouellet L, Altice F, Byers R, Kerndt P, Watters J, Bowser B, Fernando D, Holmberg S. Prevention of HIV Infection in Street-Recruited Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 25: 63-70. DOI: 10.1097/00126334-200009010-00009.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug usersHIV infectionInitial serum specimensLarge multicity studyHIV prevention strategiesHIV infection riskHIV prevention programsSyringe exchange programsDrug treatment programsUse of needlesNew AIDSHIV acquisitionHIV serostatusHIV casesPrevention strategiesSerum specimensSex partnersInfection ratePrevention programsTreatment programInfection riskStandard questionnaireHIVMultivariate model
1998
Drug abuse treatment success among needle exchange participants.
Brooner R, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Reports 1998, 113 Suppl 1: 129-39. PMID: 9722818, PMCID: PMC1307735.Peer-Reviewed Original ResearchConceptsNeedle exchange programsOpioid agonist treatment programStandard referral groupTreatment programReferral groupBetter short-term treatment outcomesNew admissionsDrug useHuman immunodeficiency virus (HIV) transmissionShort-term treatment outcomesDrug abuse treatment clinicsGreater baseline severitySelf-reported drug useDrug abuse treatment programsUse of drugsReferral patientsClinical variablesBaseline severityIncidence rateTreatment successTreatment clinicsTreatment outcomesBaseline differencesTreatment responseOutcome measures
1992
Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use
ALCABES P, VLAHOV D, ANTHONY J. Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use. The Journal Of Nervous And Mental Disease 1992, 180: 48-54. PMID: 1311371, DOI: 10.1097/00005053-199201000-00010.Peer-Reviewed Original ResearchCorrelates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?
ALCABES P, VLAHOV D, ANTHONY J. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading? Addiction 1992, 87: 47-54. PMID: 1311973, DOI: 10.1111/j.1360-0443.1992.tb01899.x.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivityDrug usersTreatment programHuman immunodeficiency virus (HIV) infectionHIV-1 seroprevalenceImmunodeficiency virus infectionHuman immunodeficiency virusDrug use characteristicsCommunity-based sampleDrug use behaviorsImmunodeficiency virusPossible selection biasRisk factorsVirus infectionType 1SeropositivityTreatmentCommunity service agenciesConfidential interviewsSelection biasSubjectsUse behaviorsExtensive distributionCorrelates
1991
New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1
Anthony J, Vlahov D, Nelson K, Conn S, Astemborski J, Solomon L. New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1. American Journal Of Epidemiology 1991, 134: 1175-1189. PMID: 1746528, DOI: 10.1093/oxfordjournals.aje.a116021.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBaltimoreBiasCausalityCocaineConfounding Factors, EpidemiologicFemaleHealth BehaviorHIV InfectionsHIV SeroprevalenceHIV-1HumansLogistic ModelsMiddle AgedPredictive Value of TestsPrevalenceProspective StudiesSexual BehaviorSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsIntravenous drug usersDrug treatment programsCocaine injectorsDrug usersHIV seroprevalenceHIV infectionHuman immunodeficiency virus type 1 (HIV-1) infectionTreatment programActive intravenous drug usersHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Preliminary prospective dataIntravenous cocaine useType 1 infectionReceptive anal intercourseMultiple logistic regressionRisk of infectionVirus type 1HIV seroconversionPresent studyExcess riskProspective dataIntravenous usePresent study sample